[Heidenhain's variant of Creutzfeldt-Jakob's disease]

M Fauquembergue1, C Tilikete, A Perret-Liaudet

  • 1Unite de Neuro-ophtalmologie et service de Neurologie D, Hospices Civils de Lyon, Hôpital Neurologique Pierre-Wertheimer, Bron.

Revue Neurologique
|August 19, 2005
PubMed

Insights

Heidenhain’s variant of Creutzfeldt-Jakob disease (CJD) presents with initial visual disturbances. Early diagnosis and prevention of iatrogenic transmission during eye exams are crucial for this rare CJD form.

Area of Science:

  • Neurology
  • Ophthalmology
  • Prion Diseases

Background:

  • Creutzfeldt-Jakob disease (CJD) exhibits diverse clinical presentations.
  • The Heidenhain variant is a rare form characterized by prominent initial visual symptoms.
  • These visual symptoms can mimic primary ophthalmological conditions, necessitating thorough differential diagnosis.

Observation:

  • A case of a 75-year-old woman with rapidly progressing isolated visual disorders over two months is presented.
  • Development of neurological symptoms, electroencephalogram (EEG) abnormalities, and positive 14-3-3 protein supported the CJD diagnosis.
  • The patient succumbed 14 months after symptom onset, with post-mortem examination confirming type 1 prion protein.

Findings:

  • The Heidenhain variant of CJD can present with isolated visual disturbances.
  • Diagnostic confirmation relies on clinical presentation, EEG, CSF biomarkers (14-3-3 protein), and ultimately post-mortem prion protein analysis.
  • This case underscores the diagnostic challenges posed by visual-predominant CJD.

Implications:

  • Highlights the importance of considering CJD in patients with unexplained, progressive visual loss.
  • Emphasizes the need for strict adherence to infection control protocols during ophthalmological procedures to prevent iatrogenic CJD transmission.
  • Underscores the critical role of neuroimaging and biomarker analysis in early CJD diagnosis.
Abstract

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...